Repligen | RGEN - 資産





資産 変化する 日付
Agilent USD 13.07B 252M 2026-03
Align Technology USD 6.42B 103.41M 2026-06
Bio Techne USD 2.55B 27.9M 2026-03
BioMarin Pharmaceutical USD 8.59B 996.99M 2026-03
Bristol-Myers Squibb USD 87.63B 1.16B 2026-06
Bruker USD 6.13B 110.7M 2026-03
Charles River Laboratories USD 7.73B 594.89M 2026-03
Danaher USD 92.37B 8.82B 2026-06
Dentsply International USD 5.23B 200M 2026-03
General Electric Aerospace USD 127.67B 773M 2026-06
Henry Schein USD 11.3B 89M 2026-03
Illumina USD 6.65B 91M 2026-06
IQVIA Holdings USD 29.88B 206M 2026-06
Mettler Toledo International USD 3.67B 2.03M 2026-06
Myriad Genetics USD 638.9M 34.8M 2026-06
OraSure Technologies USD 379.17M 24M 2026-03
Pacific Biosciences Of California USD 782.36M 1.72M 2026-03
Pfizer USD 207.62B 542M 2026-03
Repligen USD 2.95B 19.41M 2026-06
Revvity USD 12B 171.82M 2026-03
Standard Biotools USD 639.11M 71.36M 2026-03
Thermo Fisher Scientific USD 113.17B 107M 2026-06
Waters USD 24.53B 19.45B 2026-03
West Pharmaceutical Services USD 4.08B 33.4M 2026-06